Kerri Fitzgerald

DocwireNews

A 2016 13-item cross-sectional survey of 420 Americans showed that just 16 percent said they knew about cancer drug shortages, and among cancer survivors, just 31 percent were aware of shortages.Participants were more likely to be aware of drug shortages if they were white, older, employed, insured, and had more income and education. Those who were aware of the drug shortages reported hearing about it from the news or Internet.&ldquo;For those undergoing cancer treatment, shortage-driven treatment changes have the potential to impact their care,&rdquo; said lead study author Zachary Frosch, MD, of Dana-Farber Cancer Institute in Boston.Almost all respondents (87%) said they would want to know about any treatment substitutions that were made due to the drug shortages when alternative medications had major differences in effectiveness or adverse events (AEs). Sixty-one percent of participants said they would transfer care to avoid major differences in AEs, and 40 percent said they would do so to avoid just minor differences in AEs. People who were black, uninsured, or unemployed were less likely to say they would transfer care to avoid major differences in safety or efficacy.Journal:<a href="https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.31246"> Cancer</a>

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

Survey Finds Few Americans are Aware of the Cancer Drug Shortage

Oncology

A 2016 13-item cross-sectional survey of 420 Americans showed that just 16 percent said they knew about cancer drug shortages, and among cancer survivors, just 31 percent were ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe